Endocannabinoids and cannabinoid receptors in ischaemia-reperfusion injury and preconditioning.

Preconditioning with ischemia: a delay of lethal cell injury in ischemic myocardium.

Murry, C. E., Jennings, R. B., & Reimer, K. A. (1986) · Circulation · doi:10.1161/01.cir.74.5.1124 · Cited by 7,813 · see citing works

International Union of Pharmacology: Approaches to the Nomenclature of Voltage-Gated Ion Channels

Catterall, W. A., Chandy, K. G., Clapham, D. E., Gutman, G. A., Hofmann, F., Harmar, A. J., Abernethy, D. R., & Spedding, M. (2003) · Pharmacological Reviews · doi:10.1124/pr.55.4.5 · Cited by 7,126 · see citing works

Nitric Oxide and Peroxynitrite in Health and Disease

Pacher, P., Beckman, J. S., & Liaudet, L. (2007) · Physiological Reviews · doi:10.1152/physrev.00029.2006 · Cited by 6,390 · see citing works

Molecular characterization of a peripheral receptor for cannabinoids

Munro, S., Thomas, K. L., & Abu-Shaar, M. (1993) · Nature · doi:10.1038/365061a0 · Cited by 5,092 · see citing works

Structure of a cannabinoid receptor and functional expression of the cloned cDNA

Matsuda, L. A., Lolait, S. J., Brownstein, M. J., Young, A. C., & Bonner, T. I. (1990) · Nature · doi:10.1038/346561a0 · Cited by 5,011 · see citing works

The Pathophysiology and Treatment of Sepsis

Hotchkiss, R. S., & Karl, I. E. (2003) · New England Journal of Medicine · doi:10.1056/nejmra021333 · Cited by 4,098 · see citing works

NAD(P)H Oxidase: Role in Cardiovascular Biology and Disease

Griendling, K. K., Sorescu, D., & Ushio-Fukai, M. (2000) · Circulation Research · doi:10.1161/01.res.86.5.494 · Cited by 2,886 · see citing works

International Union of Pharmacology. XXVII. Classification of Cannabinoid Receptors

Howlett, A. C., Barth, F., Bonner, T. I., Cabral, G., Casellas, P., Devane, W. A., Felder, C. C., Herkenham, M., Mackie, K., Martin, B. R., et al. (2002) · Pharmacological Reviews · doi:10.1124/pr.54.2.161 · Cited by 2,819 · see citing works

Leukocyte-endothelial adhesion molecules

Carlos, T., & Harlan, J. (1994) · Blood · doi:10.1182/blood.v84.7.2068.bloodjournal8472068 · Cited by 2,500 · see citing works

The Endocannabinoid System as an Emerging Target of Pharmacotherapy

Pacher, P., Bátkai, S., & Kunos, G. (2006) · Pharmacological Reviews · doi:10.1124/pr.58.3.2 · Cited by 2,077 · see citing works

The molecular logic of endocannabinoid signalling

Piomelli, D. (2003) · Nature Reviews Neuroscience · doi:10.1038/nrn1247 · Cited by 1,957 · see citing works

Role of Endogenous Cannabinoids in Synaptic Signaling

Freund, T. F., Katona, I., & Piomelli, D. (2003) · Physiological Reviews · doi:10.1152/physrev.00004.2003 · Cited by 1,567 · see citing works

Identification and Functional Characterization of Brainstem Cannabinoid CB₂Receptors

Van Sickle, M. D., Duncan, M., Kingsley, P. J., Mouihate, A., Urbani, P., Mackie, K., Stella, N., Makriyannis, A., Piomelli, D., Davison, J. S., et al. (2005) · Science · doi:10.1126/science.1115740 · Cited by 1,470 · see citing works

Therapeutic Effects of Xanthine Oxidase Inhibitors: Renaissance Half a Century after the Discovery of Allopurinol

Pacher, P., Nivorozhkin, A., & Szabó, C. (2006) · Pharmacological Reviews · doi:10.1124/pr.58.1.6 · Cited by 1,218 · see citing works

Endocannabinoid activation at hepatic CB1 receptors stimulates fatty acid synthesis and contributes to diet-induced obesity

Osei‐Hyiaman, D., DePetrillo, M. A., Pacher, P., Liu, J., Radaeva, S., Bátkai, S., Harvey-White, J. D., Mackie, K., Offertáler, L., Wang, L., et al. (2005) · Journal of Clinical Investigation · doi:10.1172/jci23057 · Cited by 1,103 · see citing works

The endocannabinoid system and its therapeutic exploitation

Marzo, V. D., Bifulco, M., & Petrocellis, L. D. (2004) · Nature Reviews Drug Discovery · doi:10.1038/nrd1495 · Cited by 1,090 · see citing works

An endogenous cannabinoid (2-AG) is neuroprotective after brain injury

Panikashvili, D., Simeonidou, C., Ben‐Shabat, S., Hanuš, L., Breuer, A., Mechoulam, R., & Shohami, E. (2001) · Nature · doi:10.1038/35097089 · Cited by 752 · see citing works

Cannabinoid-based drugs as anti-inflammatory therapeutics

Klein, T. W. (2005) · Nature Reviews Immunology · doi:10.1038/nri1602 · Cited by 728 · see citing works

Activation of the peripheral endocannabinoid system in human obesity

Engeli, S., Böhnke, J., Feldpausch, M., Gorzelniak, K., Janke, J., Bátkai, S., Pacher, P., Harvey-White, J., Luft, F. C., Sharma, A. M., et al. (2005) · Diabetes · doi:10.2337/diabetes.54.10.2838 · Cited by 686 · cited 2× · see citing works

Pharmacological Actions of Cannabinoids

Pertwee, R. G. (2005) · Springer eBooks · doi:10.1007/3-540-26573-2_1 · Cited by 600 · see citing works

The pharmacology of cannabinoid receptors and their ligands: an overview

Pertwee, R. G. (2006) · International Journal of Obesity · doi:10.1038/sj.ijo.0803272 · Cited by 558 · see citing works

CB1 cannabinoid receptor antagonism: a new strategy for the treatment of liver fibrosis

Teixeira-Clerc, F., Julien, B., Grenard, P., Nhieu, J. T. V., Deveaux, V., Li, L., Serrière-Lanneau, V., Ledent, C. A., Mallat, A., & Lotersztajn, S. (2006) · Nature Medicine · doi:10.1038/nm1421 · Cited by 527 · see citing works

CANNABINOID RECEPTORS AS THERAPEUTIC TARGETS

Mackie, K. (2005) · The Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.46.120604.141254 · Cited by 508 · see citing works

Modulation of the cannabinoid CB 2 receptor in microglial cells in response to inflammatory stimuli

Maresz, K., Carrier, E. J., Ponomarev, E. D., Hillard, C. J., & Dittel, B. N. (2005) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2005.03380.x · Cited by 483 · see citing works

Mechanisms of Liver Injury. II. Mechanisms of neutrophil-induced liver cell injury during hepatic ischemia-reperfusion and other acute inflammatory conditions

Jaeschke, H. (2006) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00568.2005 · Cited by 478 · see citing works

Antifibrogenic role of the cannabinoid receptor CB2 in the liver

Julien, B., Grenard, P., Teixeira-Clerc, F., Nhieu, J. T. V., Li, L., Karsak, M., Zimmer, A., Mallat, A., & Lotersztajn, S. (2005) · Gastroenterology · doi:10.1053/j.gastro.2004.12.050 · Cited by 470 · see citing works

Low dose oral cannabinoid therapy reduces progression of atherosclerosis in mice

Steffens, S., Veillard, N. R., Arnaud, C., Pelli, G., Burger, F., Staub, C., Zimmer, A. D., Frossard, J., & Mach, F. (2005) · Nature · doi:10.1038/nature03389 · Cited by 469 · see citing works

Cannabinoids and Neuroprotection in Global and Focal Cerebral Ischemia and in Neuronal Cultures

Nagayama, T., Sinor, A. D., Simon, R. P., Chen, J., Graham, S. H., Jin, K., & Greenberg, D. A. (1999) · Journal of Neuroscience · doi:10.1523/jneurosci.19-08-02987.1999 · Cited by 468 · see citing works

A biosynthetic pathway for anandamide

Liu, J., Wang, L., Harvey-White, J. D., Osei‐Hyiaman, D., Razdan, R. J., Gong, Q., Chan, A. C., Zhou, Z., Huang, B. X., Kim, H., et al. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0601832103 · Cited by 468 · see citing works

Nitric oxide, superoxide, and peroxynitrite in myocardial ischaemia‐reperfusion injury and preconditioning

Ferdinándy, P., & Schulz, R. (2003) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0705080 · Cited by 439 · see citing works

Platelet‐ and macrophage‐derived endogenous cannabinoids are involved in endotoxin‐induced hypotension

Varga, K., Wagner, J. A., Bridgen, D. T., & Kunos, G. (1998) · The FASEB Journal · doi:10.1096/fasebj.12.11.1035 · Cited by 410 · see citing works

Evidence for novel cannabinoid receptors

Begg, M., Pacher, P., Bátkai, S., Osei‐Hyiaman, D., Offertáler, L., Mo, F.-M., LIU, J., & Kunos, G. (2005) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2004.11.005 · Cited by 385 · see citing works

Endocannabinoids acting at vascular CB1 receptors mediate the vasodilated state in advanced liver cirrhosis

Bátkai, S., Járai, Z., Wagner, J. A., Goparaju, S. K., Varga, K., Liu, J., Wang, L., Mirshahi, F., Khanolkar, A. D., Makriyannis, A., et al. (2001) · Nature Medicine · doi:10.1038/89953 · Cited by 376 · see citing works

Mecanismos de lesión hepatocelular

Muntané, J., González, R., Ranchal, I., Collado, J. A., Lopez-Sanchez, L. M., Herencia, C., Rodríguez‐Ariza, A., Muñoz-Castañeda, J. R., & de la Mata, M. (2007) · Revista Española de Enfermedades Digestivas · doi:10.4321/s1130-01082007000700007 · Cited by 349 · see citing works

Functional CB1 cannabinoid receptors in human vascular endothelial cells

Liu, J., Gao, B., Mirshahi, F., Sanyal, A. J., Khanolkar, A. D., Makriyannis, A., & Kunos, G. (2000) · Biochemical Journal · doi:10.1042/bj3460835 · Cited by 335 · see citing works

Cannabinoids and neuroinflammation

Walter, L. M., & Stella, N. (2004) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0705667 · Cited by 334 · see citing works

Endocannabinoids Acting at Cannabinoid-1 Receptors Regulate Cardiovascular Function in Hypertension

Bátkai, S., Pacher, P., Osei‐Hyiaman, D., Radaeva, S., Liu, J., Harvey-White, J. D., Offertáler, L., Mackie, K., Rudd, M. A., Bukoski, R. D., et al. (2004) · Circulation · doi:10.1161/01.cir.0000143230.23252.d2 · Cited by 322 · see citing works

Cannabinoid CB1 receptor of cat cerebral arterial muscle functions to inhibit L-type Ca2+channel current

Gebremedhin, D., Lange, A. R., Campbell, W. B., Hillard, C. J., & Harder, D. R. (1999) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.1999.276.6.h2085 · Cited by 308 · see citing works

Inhibition of tumor angiogenesis by cannabinoids

Blázquez, C., Casanova, M., Planas, A. M., del Pulgar, T. G., Villanueva, C., Fernández‐Aceñero, M. J., Aragonés, J., Huffman, J. W., Jorcano, J. L., & Guzmán, M. (2003) · The FASEB Journal · doi:10.1096/fj.02-0795fje · Cited by 292 · see citing works

Endocannabinoids and the regulation of their levels in health and disease

Marzo, V. D., & Petrosino, S. (2007) · Current Opinion in Lipidology · doi:10.1097/mol.0b013e32803dbdec · Cited by 289 · see citing works

Preconditioning and postconditioning: United at reperfusion

Hausenloy, D. J., & Yellon, D. M. (2007) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2007.06.005 · Cited by 285 · see citing works

Activation of peripheral CB1 cannabinoid receptors in haemorrhagic shock

Wagner, J. A., Varga, K., Ellis, E. F., Rzigalinski, B. A., Martin, B. R., & Kunos, G. (1997) · Nature · doi:10.1038/37371 · Cited by 283 · see citing works

Potent Metalloporphyrin Peroxynitrite Decomposition Catalyst Protects Against the Development of Doxorubicin-Induced Cardiac Dysfunction

Pacher, P., Liaudet, L., Bai, P., Mabley, J. G., Kaminski, P. M., Virág, L., Deb, A., Szabó, É., Ungvari, Z. I., Wolin, M. S., et al. (2003) · Circulation · doi:10.1161/01.cir.0000048192.52098.dd · Cited by 279 · see citing works

Cannabinoid receptors and endocannabinoids: Evidence for new players

Mackie, K., & Stella, N. (2006) · The AAPS Journal · doi:10.1007/bf02854900 · Cited by 275 · see citing works

CB2-receptor stimulation attenuates TNF-α-induced human endothelial cell activation, transendothelial migration of monocytes, and monocyte-endothelial adhesion

Rajesh, M., Mukhopadhyay, P., Bátkai, S., Haskó, G., Liaudet, L., Huffman, J. W., Csiszár, A., Ungvari, Z. I., Mackie, K., Chatterjee, S. B., et al. (2007) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00688.2007 · Cited by 262 · see citing works

Sequential observation of micrometastasis formation by bacterial lacZ gene-tagged Lewis lung carcinoma cells

Kobayashi, K., Nakanishi, H., Masuda, A., Tezuka, N., Mutai, M., & Tatematsu, M. (1997) · Cancer Letters · doi:10.1016/s0304-3835(96)04569-7 · Cited by 257 · see citing works

Human brain endothelium: coexpression and function of vanilloid and endocannabinoid receptors

Golech, S., McCarron, R. M., Chen, Y., Bembry, J., Lenz, F. A., Mechoulam, R., Shohami, E., & Spatz, M. (2004) · Molecular Brain Research · doi:10.1016/j.molbrainres.2004.08.025 · Cited by 248 · see citing works

Cannabinoid‐2 receptor mediates protection against hepatic ischemia/reperfusion injury

Bátkai, S., Osei‐Hyiaman, D., Pan, H., El-Assal, O. N., Rajesh, M., Mukhopadhyay, P., Hong, F., Harvey-White, J. D., Jafri, A., Haskó, G., et al. (2007) · The FASEB Journal · doi:10.1096/fj.06-7451com · Cited by 246 · see citing works

The novel endocannabinoid receptor GPR55 is activated by atypical cannabinoids but does not mediate their vasodilator effects

Johns, D. G., Behm, D. J., Walker, D. J., Zhang, A., Shapland, E. M., Daniels, D. A., Riddick, M., Dowell, S. J., Staton, P. C., Green, P., et al. (2007) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0707419 · Cited by 242 · see citing works

Therapeutic Potential of Cannabinoids in CNS Disease

Croxford, J. L. (2003) · CNS Drugs · doi:10.2165/00023210-200317030-00004 · Cited by 240 · see citing works

Endogenous cannabinoids: A new system involved in the homeostasis of arterial pressure in experimental cirrhosis in the rat

Ros, J., Clària, J., To‐Figueras, J., Planagumà, A., Cejudo–Martín, P., Fernández‐Varo, G., Martín‐Ruiz, R., Arroyo, V., Rivera, F., Rodés, J., et al. (2002) · Gastroenterology · doi:10.1053/gast.2002.30305 · Cited by 237 · see citing works

Nitrosative stress and pharmacological modulation of heart failure

Pacher, P., Schulz, R., Liaudet, L., & Szabó, C. (2005) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2005.04.003 · Cited by 237 · see citing works

Occurrence and postmortem generation of anandamide and other long‐chain N‐acylethanolamines in mammalian brain

Schmid, P. C., Krebsbach, R. J., Perry, S. R., Dettmer, T. M., Maasson, J. L., & Schmid, H. H. O. (1995) · FEBS Letters · doi:10.1016/0014-5793(95)01194-j · Cited by 235 · see citing works

Lipopolysaccharide Induces Anandamide Synthesis in Macrophages via CD14/MAPK/Phosphoinositide 3-Kinase/NF-κB Independently of Platelet-activating Factor

Liu, J., Bátkai, S., Pacher, P., Harvey-White, J. D., Wagner, J. A., Cravatt, B. F., Gao, B., & Kunos, G. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m306062200 · Cited by 234 · see citing works

The endocannabinoid 2-AG protects the blood–brain barrier after closed head injury and inhibits mRNA expression of proinflammatory cytokines

Panikashvili, D., Shein, N. A., Mechoulam, R., Trembovler, V., Kohen, R., Alexandrovich, A. G., & Shohami, E. (2005) · Neurobiology of Disease · doi:10.1016/j.nbd.2005.11.004 · Cited by 229 · see citing works

Cannabinoids and brain injury: therapeutic implications

Mechoulam, R. (2002) · Trends in Molecular Medicine · doi:10.1016/s1471-4914(02)02276-1 · Cited by 229 · see citing works

Increased Severity of Stroke in CB1 Cannabinoid Receptor Knock-Out Mice

Parmentier‐Batteur, S., Jin, K., Mao, X. O., Xie, L., & Greenberg, D. A. (2002) · Journal of Neuroscience · doi:10.1523/jneurosci.22-22-09771.2002 · Cited by 225 · see citing works

Pharmacological Inhibition of CB1Cannabinoid Receptor Protects Against Doxorubicin-Induced Cardiotoxicity

Mukhopadhyay, P., Bátkai, S., Rajesh, M., Czifra, N., Harvey-White, J. D., Haskó, G., Zsengellér, Z. K., Gerard, N. P., Liaudet, L., Kunos, G., et al. (2007) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2007.03.057 · Cited by 208 · see citing works

Role of Oxidative-Nitrosative Stress and Downstream Pathways in Various Forms of Cardiomyopathy and Heart Failure

Ungvari, Z. I., Gupte, S. A., Recchia, F. A., Bátkai, S., & Pacher, P. (2005) · Current Vascular Pharmacology · doi:10.2174/1570161054368607 · Cited by 205 · see citing works

The therapeutic potential of drugs that target cannabinoid receptors or modulate the tissue levels or actions of endocannabinoids

Pertwee, R. G. (2005) · The AAPS Journal · doi:10.1208/aapsj070364 · Cited by 204 · see citing works

Modulation of Leukocyte-Mediated Myocardial Reperfusion Injury

Lucchesi, B. R. (1990) · Annual Review of Physiology · doi:10.1146/annurev.ph.52.030190.003021 · Cited by 204 · see citing works

Neuroprotective Antioxidants from Marijuana a

Hampson, A. J., GRIMALDI, M., Miljkovic-Lolic, M., Wink, D. A., Rosenthal, R., & Axelrod, J. (2000) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2000.tb06193.x · Cited by 203 · see citing works

Preconditioning: a paradigm shift in the biology of myocardial ischemia

Bolli, R. (2006) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00712.2006 · Cited by 201 · see citing works

Mechanisms of Inflammatory Liver Injury: Adhesion Molecules and Cytotoxicity of Neutrophils

Jaeschke, H., Smith, C. W., Clemens, M. G., Ganey, P. E., & Roth, R. A. (1996) · Toxicology and Applied Pharmacology · doi:10.1006/taap.1996.0160 · Cited by 189 · see citing works

CB 1 cannabinoid receptors are involved in neuroprotection via NF-κB inhibition

Panikashvili, D., Mechoulam, R., Beni, S. M., Alexandrovich, A. G., & Shohami, E. (2005) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/sj.jcbfm.9600047 · Cited by 180 · see citing works

Endocannabinoids protect cerebral cortical neurons from in vitro ischemia in rats

Sinor, A. D., Irvin, S. M., & Greenberg, D. A. (2000) · Neuroscience Letters · doi:10.1016/s0304-3940(99)00922-2 · Cited by 175 · see citing works

Anandamide induces necrosis in primary hepatic stellate cells†‡

Siegmund, S., Uchinami, H., Osawa, Y., Brenner, D. A., & Schwabe, R. F. (2005) · Hepatology · doi:10.1002/hep.20667 · Cited by 171 · see citing works

Effects of Cannabinoid Receptor Agonist and Antagonist Ligands on Production of Inflammatory Cytokines and Anti-Inflammatory Interleukin-10 in Endotoxemic Mice

Smith, S. R., Terminelli, C., & Denhardt, G. (2000) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)39213-4 · Cited by 170 · see citing works

Cardiovascular Pharmacology of Cannabinoids

Pacher, P., Bátkai, S., & Kunos, G. (2005) · Springer eBooks · doi:10.1007/3-540-26573-2_20 · Cited by 167 · see citing works

Cannabinoid CB 2 Receptor Activation Decreases Cerebral Infarction in a Mouse Focal Ischemia/Reperfusion Model

Zhang, M., Martin, B. R., Adler, M. W., Razdan, R. K., Jallo, J., & Tuma, R. F. (2007) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/sj.jcbfm.9600447 · Cited by 165 · see citing works

Lipopolysaccharide Downregulates Fatty Acid Amide Hydrolase Expression and Increases Anandamide Levels in Human Peripheral Lymphocytes

Maccarrone, M., PETROCELLIS, L. D., Bari, M., Fezza, F., Salvati, S., Marzo, V. D., & Finazzi‐Agrò, A. (2001) · Archives of Biochemistry and Biophysics · doi:10.1006/abbi.2001.2500 · Cited by 162 · see citing works

Massive accumulation of N‐acylethanolamines after stroke. Cell signalling in acute cerebral ischemia?

Berger, C., Schmid, P. C., Schäbitz, W.-R., Wolf, M., Schwab, S., & Schmid, H. H. O. (2004) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2003.02244.x · Cited by 154 · see citing works

Pivotal Advance: Cannabinoid-2 receptor agonist HU-308 protects against hepatic ischemia/reperfusion injury by attenuating oxidative stress, inflammatory response, and apoptosis

Rajesh, M., Pan, H., Mukhopadhyay, P., Bátkai, S., Osei‐Hyiaman, D., Haskó, G., Liaudet, L., Gao, B., & Pacher, P. (2007) · Journal of Leukocyte Biology · doi:10.1189/jlb.0307180 · Cited by 150 · see citing works

Cannabinoid Receptors and Endocannabinoids: Evidence for New Players

Mackie, K., & Stella, N. (2006) · The AAPS Journal · doi:10.1208/aapsj080234 · Cited by 149 · see citing works

Endogenous cannabinoids mediate hypotension after experimental myocardial infarction

Wagner, J. A., Hu, K., Bauersachs, J. K., Karcher, J. C., Wiesler, M., Goparaju, S. K., Kunos, G., & Ertl, G. (2001) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(01)01671-0 · Cited by 147 · see citing works

Endocannabinoids and Neuroprotection

Mechoulam, R., Spatz, M., & Shohami, E. (2002) · Science s STKE · doi:10.1126/stke.2002.129.re5 · Cited by 147 · see citing works

Anandamide content is increased and CB1 cannabinoid receptor blockade is protective during transient, focal cerebral ischemia

Muthian, S., Rademacher, D. J., Roelke, C. T., Gross, G. J., & Hillard, C. J. (2004) · Neuroscience · doi:10.1016/j.neuroscience.2004.08.044 · Cited by 143 · see citing works

Involvement of the Endocannabinoid System in Retinal Damage after High Intraocular Pressure–Induced Ischemia in Rats

Nucci, C., Gasperi, V., Tartaglione, R., Cerulli, A., Terrinoni, A., Bari, M., Simone, C. D., Finazzi‐Agrò, A., Morrone, L. A., Corasaniti, M. T., et al. (2007) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.06-1355 · Cited by 137 · see citing works

Cellular adhesion molecules: regulation and functional significance in the pathogenesis of liver diseases

Jaeschke, H. (1997) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.1997.273.3.g602 · Cited by 136 · see citing works

Endocannabinoids protect the rat isolated heart against ischaemia

Lépicier, P., Bouchard, J., Lagneux, C., & Lamontagne, D. (2003) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0705313 · Cited by 133 · see citing works

Cardiovascular effects of cannabinoids

Randall, M. D., Harris, D., Kendall, D. A., & Ralevic, V. (2002) · Pharmacology & Therapeutics · doi:10.1016/s0163-7258(02)00258-9 · Cited by 132 · see citing works

Cerebral hypoxia-ischemia and middle cerebral artery occlusion induce expression of the cannabinoid CB2 receptor in the brain

Ashton, J. C., Rahman, R. M. A., Nair, S. M., Sutherland, B. A., Glass, M., & Appleton, I. (2006) · Neuroscience Letters · doi:10.1016/j.neulet.2006.10.053 · Cited by 131 · see citing works

Role of endocannabinoids in the pathogenesis of cirrhotic cardiomyopathy in bile duct‐ligated rats

Gaskari, S. A., Liu, H., Moezi, L., Li, Y., Baik, S. K., & Lee, S. S. (2005) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0706331 · Cited by 128 · see citing works

Cannabinoid CB2 receptor activation reduces mouse myocardial ischemia-reperfusion injury: involvement of cytokine/chemokines and PMN

Filippo, C. D., Rossi, F., Rossi, S., & D’Amico, M. (2003) · Journal of Leukocyte Biology · doi:10.1189/jlb.0703303 · Cited by 128 · see citing works

Anandamide initiates Ca2+ signaling via CB2 receptor linked to phospholipase C in calf pulmonary endothelial cells

Zoratti, C., Kipmen‐Korgun, D., Osibow, K., Malli, R., & Graier, W. F. (2003) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0705529 · Cited by 127 · see citing works

Management of acute ischaemic stroke: new guidelines from the American Stroke Association and European Stroke Initiative

Klijn, C. J. M., & Hankey, G. J. (2003) · The Lancet Neurology · doi:10.1016/s1474-4422(03)00558-1 · Cited by 127 · see citing works

Cannabinoids: Between Neuroprotection and Neurotoxicity

Sarne, Y., & Mechoulam, R. (2005) · CNS & Neurological Disorders - Drug Targets · doi:10.2174/156800705774933005 · Cited by 120 · see citing works

Endocannabinoids acting at CB1receptors mediate the cardiac contractile dysfunction in vivo in cirrhotic rats

Bátkai, S., Mukhopadhyay, P., Harvey-White, J. D., Kechrid, R., Pacher, P., & Kunos, G. (2007) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00538.2007 · Cited by 118 · see citing works

Drug-Induced Hypothermia Reduces Ischemic Damage

Leker, R. R., Gai, N., Mechoulam, R., & Ovadia, H. (2003) · Stroke · doi:10.1161/01.str.0000079817.68944.1e · Cited by 115 · see citing works

Release of Fatty Acid Amides in a Patient With Hemispheric Stroke

Schäbitz, W.-R., Giuffrida, A., Berger, C., Aschoff, A. A., Schwaninger, M., Schwab, S., & Piomelli, D. (2002) · Stroke · doi:10.1161/01.str.0000023491.63693.18 · Cited by 111 · see citing works

Realizing the clinical potential of ischemic preconditioning and postconditioning

Yellon, D. M., & Hausenloy, D. J. (2005) · Nature Clinical Practice Cardiovascular Medicine · doi:10.1038/ncpcardio0346 · Cited by 105 · see citing works

Involvement of cannabinoids in the cardioprotection induced by lipopolysaccharide

Lagneux, C., & Lamontagne, D. (2001) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0703902 · Cited by 97 · see citing works

Cannabinoids as therapeutic agents in cardiovascular disease: a tale of passions and illusions

Mendizábal, V. E., & Adler‐Graschinsky, E. (2007) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0707261 · Cited by 97 · see citing works

Characterization of the Diarylether Sulfonylester (−)-(R)-3-(2-Hydroxymethylindanyl-4-oxy)phenyl-4,4,4-trifluoro-1-sulfonate (BAY 38-7271) as a Potent Cannabinoid Receptor Agonist with Neuroprotective Properties

Mauler, F., Mittendorf, J., Horváth, E., & Vry, J. D. (2002) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.302.1.359 · Cited by 97 · see citing works

Fatty Acid Amide Hydrolase Determines Anandamide-induced Cell Death in the Liver

Siegmund, S., Seki, E., Osawa, Y., Uchinami, H., Cravatt, B. F., & Schwabe, R. F. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m509706200 · Cited by 94 · see citing works

Contribution of endocannabinoids in the endothelial protection afforded by ischemic preconditioning in the isolated rat heart

Bouchard, J., Lépicier, P., & Lamontagne, D. (2003) · Life Sciences · doi:10.1016/s0024-3205(02)02474-8 · Cited by 93 · see citing works

Endocannabinoids are implicated in the infarct size-reducing effect conferred by heat stress preconditioning in isolated rat hearts

Joyeux‐Faure, M. (2002) · Cardiovascular Research · doi:10.1016/s0008-6363(02)00268-7 · Cited by 92 · see citing works

The anti-inflammatory activities of cannabinoid receptor ligands in mouse peritonitis models

Smith, S. R., Denhardt, G., & Terminelli, C. (2001) · European Journal of Pharmacology · doi:10.1016/s0014-2999(01)01477-7 · Cited by 91 · see citing works

Blood pressure regulation by endocannabinoids and their receptors

Pacher, P., Bátkai, S., & Kunos, G. (2005) · Neuropharmacology · doi:10.1016/j.neuropharm.2004.12.005 · Cited by 91 · see citing works

Anandamide mediates hyperdynamic circulation in cirrhotic rats via CB1 and VR1 receptors

Moezi, L., Gaskari, S. A., Liu, H., Baik, S. K., Dehpour, A. R., & Lee, S. S. (2006) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0706928 · Cited by 82 · see citing works

Hemodynamic profile, responsiveness to anandamide, and baroreflex sensitivity of mice lacking fatty acid amide hydrolase

Pacher, P., Bátkai, S., Osei‐Hyiaman, D., Offertáler, L., Liu, J., Harvey-White, J., Brassai, A., Járai, Z., Cravatt, B. F., & Kunos, G. (2005) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00107.2005 · Cited by 79 · see citing works

Anandamide reduces infarct size in rat isolated hearts subjected to ischaemia–reperfusion by a novel cannabinoid mechanism

Underdown, N. J., Hiley, C. R., & Ford, W. R. (2005) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0706391 · Cited by 71 · see citing works

Cannabinoid pharmacology in the cardiovascular system: potential protective mechanisms through lipid signalling

Hiley, C. R., & Ford, W. R. (2004) · Biological reviews/Biological reviews of the Cambridge Philosophical Society · doi:10.1017/s1464793103006201 · Cited by 70 · see citing works

Delta-9-tetrahydrocannabinol protects cardiac cells from hypoxia via CB2 receptor activation and nitric oxide production

Shmist, Y. A., Goncharov, I., Eichler, M., Shneyvays, V., Isaac, A., Vogel, Z., & Shainberg, A. (2006) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-006-2346-y · Cited by 68 · see citing works

Cannabinoid antagonist SR-141716 inhibits endotoxic hypotension by a cardiac mechanism not involving CB1 or CB2 receptors

Bátkai, S., Pacher, P., Járai, Z., Wagner, J. A., & Kunos, G. (2004) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00184.2004 · Cited by 64 · see citing works

CB 1 cannabinoid receptor antagonism promotes remodeling and cannabinoid treatment prevents endothelial dysfunction and hypotension in rats with myocardial infarction

Wagner, J. A., Hu, K., Karcher, J. C., Bauersachs, J. K., Schäfer, A., Laser, M., Han, H. J., & Ertl, G. (2003) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0705156 · Cited by 63 · see citing works

Cannabinoid receptors as new targets of antifibrosing strategies during chronic liver diseases

Mallat, A., Teixeira-Clerc, F., Deveaux, V., & Lotersztajn, S. (2007) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728222.11.3.403 · Cited by 61 · see citing works

Cannabidiol prevents infarction via the non-CB1 cannabinoid receptor mechanism

Hayakawa, K., Mishima, K., Abe, K., Hasebe, N., Takamatsu, F., Yasuda, H., Ikeda, T., Inui, K., Egashira, N., Iwasaki, K., et al. (2004) · Neuroreport · doi:10.1097/00001756-200410250-00016 · Cited by 56 · see citing works

The synthetic cannabinoid WIN 55,212-2 increases COX-2 expression and PGE2 release in murine brain-derived endothelial cells following Theiler's virus infection

Mestre, L., Correa, F., Docagne, F., Clemente, D., & Guaza, C. (2006) · Biochemical Pharmacology · doi:10.1016/j.bcp.2006.06.037 · Cited by 54 · see citing works

Resorcinol Derivatives: A Novel Template for the Development of Cannabinoid CB1/CB2 and CB2-Selective Agonists

Wiley, J. L., Beletskaya, I. D., Ng, E. W., Dai, Z., Crocker, P. J., Mahadevan, A., Razdan, R. K., & Martin, B. R. (2002) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.301.2.679 · Cited by 54 · see citing works

Additional Outcomes and Subgroup Analyses of NXY-059 for Acute Ischemic Stroke in the SAINT I Trial

Lees, K. R., Dávalos, A., Davis, S. M., Diener, H., Grotta, J. C., Lyden, P. D., Shuaib, A. M., Ashwood, T. J., Hårdemark, H., Wasiewski, W. W., et al. (2006) · Stroke · doi:10.1161/01.str.0000249410.91473.44 · Cited by 53 · see citing works

2-Arachidonylglycerol Acting on CB1 Cannabinoid Receptors Mediates Delayed Cardioprotection Induced by Nitric Oxide in Rat Isolated Hearts

Wagner, J. A., Abeßer, M., Harvey-White, J. D., & Ertl, G. (2006) · Journal of Cardiovascular Pharmacology · doi:10.1097/01.fjc.0000211752.08949.eb · Cited by 52 · see citing works

Activation of Type II Cannabinoid Receptors Improves Myocardial Tolerance to Arrhythmogenic Effects of Coronary Occlusion and Reperfusion

Krylatov, A. V., Ugdyzhekova, D. S., Бернацкая, Н. А., Маслов, Л. Н., Mekhoulam, R., Pertwee, R. G., & Stephano, G. B. (2001) · Bulletin of Experimental Biology and Medicine · doi:10.1023/a:1012381914518 · Cited by 51 · see citing works

The effect of δ-9-tetrahydrocannabinol on forebrain ischemia in rat

Louw, D. F., Yang, F. W., & Sutherland, G. R. (2000) · Brain Research · doi:10.1016/s0006-8993(99)02422-1 · Cited by 51 · see citing works

The Cannabinoid 1 Receptor Antagonist, AM251, Prolongs the Survival of Rats with Severe Acute Pancreatitis

Matsuda, K., Mikami, Y., Takeda, K., Fukuyama, S., Egawa, S., Sunamura, M., Maruyama, I., & Matsuno, S. (2005) · The Tohoku Journal of Experimental Medicine · doi:10.1620/tjem.207.99 · Cited by 50 · see citing works

Neuroprotective cannabinoid receptor antagonist SR141716A prevents downregulation of excitotoxic NMDA receptors in the ischemic penumbra

Sommer, C., Schomacher, M., Berger, C., Kuhnert, K., Müller, H. D., Schwab, S., & Schäbitz, W. (2006) · Acta Neuropathologica · doi:10.1007/s00401-006-0110-8 · Cited by 48 · see citing works

GPR55 and the vascular receptors for cannabinoids

Hiley, C. R., & Kaup, S. S. (2007) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0707421 · Cited by 44 · see citing works

Effect of chronic CB1 cannabinoid receptor antagonism on livers of rats with biliary cirrhosis

Yang, Y., Lin, H., Huang, Y., Lee, T.-Y., Hou, M., Wang, Y., Lee, F., & Lee, S. (2007) · Clinical Science · doi:10.1042/cs20060260 · Cited by 39 · see citing works

Role of Nitrosative Stress and Activation of Poly(ADP-ribose) Polymerase-1 in Cardiovascular Failure Associated with Septic and Hemorrhagic Shock

Evgenov, O. V., & Liaudet, L. (2005) · Current Vascular Pharmacology · doi:10.2174/1570161054368580 · Cited by 38 · see citing works

The endogenous cardiac cannabinoid system: a new protective mechanism against myocardial ischemia.

Lamontagne, D., Lépicier, P., Lagneux, C., & Bouchard, J. (2006) · PubMed · Cited by 35 · see citing works

Differential cardiac gene expression during cardiopulmonary bypass: Ischemia-independent upregulation of proinflammatory genes

Podgoreanu, M. V., Michelotti, G. A., Sato, Y., Smith, M. P., Lin, S. M., Morris, R. W., Grocott, H. P., Mathew, J. P., & Schwinn, D. A. (2005) · Journal of Thoracic and Cardiovascular Surgery · doi:10.1016/j.jtcvs.2004.11.052 · Cited by 34 · see citing works

Signaling Pathways Involved in the Cardioprotective Effects of Cannabinoids

Lépicier, P., Bibeau-Poirier, A., Lagneux, C., Servant, M. J., & Lamontagne, D. (2006) · Journal of Pharmacological Sciences · doi:10.1254/jphs.crj06011x · Cited by 33 · see citing works

2-Arachidonoylglycerol Increases in Ischemia–Reperfusion Injury of the Rat Liver

Kurabayashi, M., Takeyoshi, I., Yoshinari, D., Matsumoto, K., Maruyama, I., & Morishita, Y. (2005) · Journal of Investigative Surgery · doi:10.1080/08941930590905189 · Cited by 32 · see citing works

Endogenous Cannabinoid Anandamide Increases Heart Resistance to Arrhythmogenic Effects of Epinephrine: Role of CB1 and CB2 Receptors

Ugdyzhekova, D. S., Бернацкая, Н. А., Stefano, J. B., Graier, V. F., Tam, S. W., & Mekhoulam, R. (2001) · Bulletin of Experimental Biology and Medicine · doi:10.1023/a:1017651432193 · Cited by 29 · see citing works

Cannabinoid antagonist AM 281 reduces mortality rate and neurologic dysfunction after cecal ligation and puncture in rats

Kadoi, Y., Hinohara, H., Kunimoto, F., Saito, S., & Goto, F. (2005) · Critical Care Medicine · doi:10.1097/01.ccm.0000187010.14426.cc · Cited by 27 · see citing works

Activation of Cannabinoid Receptors Decreases the Area of Ischemic Myocardial Necrosis

Ugdyzhekova, D. S., Krylatov, A. V., Бернацкая, Н. А., Маслов, Л. Н., Mechoulam, R., & Pertwee, R. G. (2002) · Bulletin of Experimental Biology and Medicine · doi:10.1023/a:1015526217332 · Cited by 18 · see citing works

Cirrhotic cardiomyopathy: an endocannabinoid connection?

Pacher, P., Bátkai, S., & Kunos, G. (2005) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0706332 · Cited by 18 · see citing works

[Anandamide and R-(+)-methanandamide prevent development of ischemic and reperfusion arrhythmia in rats by stimulation of CB2-receptors].

Krylatov, A. V., Uzhachenko, R. V., Маслов, Л. Н., Ugdyzhekova, D. S., Бернацкая, Н. А., Pertwee, R. G., Stefano, G. B., & Makriyannis, A. (2002) · PubMed · Cited by 17 · see citing works

Effects of AM281, a cannabinoid antagonist, on circulatory deterioration and cytokine production in an endotoxin shock model: comparison with norepinephrine

Kadoi, Y., & Goto, F. (2006) · Journal of Anesthesia · doi:10.1007/s00540-006-0428-3 · Cited by 17 · see citing works

[Increase of the heart arrhythmogenic resistance and decrease of the myocardial necrosis zone during activation of cannabinoid receptors].

Krylatov, A. V., Бернацкая, Н. А., Маслов, Л. Н., Pertwee, R. G., Mechoulam, R., Stefano, G. B., Ma, S., & Om, S. (2002) · PubMed · Cited by 12 · see citing works

Kupffer’s cells modulate neutrophile activity by superoxide anion and tumor necrosis factor–∂ in reperfusion injury of liver transplantation-mechanisms of radical generation and reperfusion injury after cold ischemia

Ohkohchi, N., Shibuya, H., Tsukamoto, S., Sakurada, M., Oikawa, K., Terashima, T., & Satomi, S. (1999) · Transplantation Proceedings · doi:10.1016/s0041-1345(98)01902-2 · Cited by 10 · see citing works

Cannabinoid CB1 receptor blockade enhances the protective effect of melanocortins in hemorrhagic shock in the rat

Cainazzo, M. M., Ferrazza, G., Mioni, C., Bazzani, C., Bertolini, A., & Guarini, S. (2002) · European Journal of Pharmacology · doi:10.1016/s0014-2999(02)01487-5 · Cited by 8 · see citing works

Cardiovascular effects of marijuana and synthetic cannabinoids: the good, the bad, and the ugly

Pacher, P., Steffens, S., Haskó, G., Schindler, T. H., & Kunos, G. (2017) · Nature Reviews Cardiology · doi:10.1038/nrcardio.2017.130 · Cited by 438 · see citing works

Emerging strategies for exploiting cannabinoid receptor agonists as medicines

Pertwee, R. G. (2009) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2008.00048.x · Cited by 436 · see citing works

Is lipid signaling through cannabinoid 2 receptors part of a protective system?

Pacher, P., & Mechoulam, R. (2011) · Progress in Lipid Research · doi:10.1016/j.plipres.2011.01.001 · Cited by 420 · see citing works

Role of liver sinusoidal endothelial cells in liver diseases

Gracia‐Sancho, J., Caparrós, E., Fernández‐Iglesias, A., & Francés, R. (2021) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-020-00411-3 · Cited by 425 · see citing works

Modulating the endocannabinoid system in human health and disease – successes and failures

Pacher, P., & Kunos, G. (2013) · FEBS Journal · doi:10.1111/febs.12260 · Cited by 406 · see citing works

Targeting the endocannabinoid system with cannabinoid receptor agonists: pharmacological strategies and therapeutic possibilities

Pertwee, R. G. (2012) · Philosophical Transactions of the Royal Society B Biological Sciences · doi:10.1098/rstb.2011.0381 · Cited by 351 · see citing works

Lipid G Protein-coupled Receptor Ligand Identification Using β-Arrestin PathHunter™ Assay

Yin, H., Chu, A., Li, W., Wang, B., Shelton, F., Otero, F. J., Nguyen, D. G., Caldwell, J. S., & Chen, Y. A. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m806516200 · Cited by 313 · see citing works

The endocannabinoid system of the skin in health and disease: novel perspectives and therapeutic opportunities

Bı́ró, T., Tóth, B. I., Haskó, G., Paus, R., & Pacher, P. (2009) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2009.05.004 · Cited by 277 · see citing works

CB2 Cannabinoid Receptors as a Therapeutic Target—What Does the Future Hold?

Dhopeshwarkar, A., & Mackie, K. (2014) · Molecular Pharmacology · doi:10.1124/mol.114.094649 · Cited by 254 · see citing works

Cannabinoid-2 receptor limits inflammation, oxidative/nitrosative stress, and cell death in nephropathy

Mukhopadhyay, P., Rajesh, M., Pan, H., Patel, V., Mukhopadhyay, B., Bátkai, S., Gao, B., Haskó, G., & Pacher, P. (2009) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2009.11.022 · Cited by 217 · see citing works

Cannabidiol protects against hepatic ischemia/reperfusion injury by attenuating inflammatory signaling and response, oxidative/nitrative stress, and cell death

Mukhopadhyay, P., Rajesh, M., Horváth, B., Bátkai, S., Park, O., Tanchian, G., Gao, R. Y., Patel, V., Wink, D. A., Liaudet, L., et al. (2011) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2011.02.021 · Cited by 206 · see citing works

The Endothelium, Part I: Multiple Functions of the Endothelial Cells -- Focus on Endothelium-Derived Vasoactive Mediators

Félétou, M. (2011) · Colloquium Series on Integrated Systems Physiology From Molecule to Function · doi:10.4199/c00031ed1v01y201105isp019 · Cited by 202 · see citing works

CB1 cannabinoid receptors promote oxidative stress and cell death in murine models of doxorubicin-induced cardiomyopathy and in human cardiomyocytes

Mukhopadhyay, P., Rajesh, M., Bátkai, S., Patel, V., Kashiwaya, Y., Liaudet, L., Evgenov, O. V., Mackie, K., Haskó, G., & Pacher, P. (2009) · Cardiovascular Research · doi:10.1093/cvr/cvp369 · Cited by 199 · see citing works

Emerging role of cannabinoids in gastrointestinal and liver diseases: basic and clinical aspects

Izzo, A. A., & Camilleri, M. (2008) · Gut · doi:10.1136/gut.2008.148791 · Cited by 197 · see citing works

Goods and Bads of the Endocannabinoid System as a Therapeutic Target: Lessons Learned after 30 Years

Maccarrone, M., Di Marzo, V., Gertsch, J., Grether, U., Howlett, A. C., Hua, T., Makriyannis, A., Piomelli, D., Ueda, N., & van der Stelt, M. (2023) · Pharmacological Reviews · doi:10.1124/pharmrev.122.000600 · Cited by 183 · see citing works

CB2 cannabinoid receptor activation is cardioprotective in a mouse model of ischemia/reperfusion

Montecucco, F., Lenglet, S., Braunersreuther, V., Burger, F., Pelli, G., Bertolotto, M. B., Mach, F., & Steffens, S. (2009) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2008.12.014 · Cited by 182 · see citing works

Endocannabinoids and traumatic brain injury

Shohami, E., Cohen‐Yeshurun, A., Magid, L., Algali, M., & Mechoulam, R. (2011) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2011.01343.x · Cited by 168 · see citing works

Role of the endocannabinoid system in diabetes and diabetic complications

Gruden, G., Barutta, F., Kunos, G., & Pacher, P. (2015) · British Journal of Pharmacology · doi:10.1111/bph.13226 · Cited by 168 · see citing works

Activation of cannabinoid 2 receptors protects against cerebral ischemia by inhibiting neutrophil recruitment

Murikinati, S. R., Jüttler, E., Keinert, T., Ridder, D. A., Muhammad, S., Waibler, Z., Ledent, C. A., Zimmer, A., Kalinke, U., & Schwaninger, M. (2009) · The FASEB Journal · doi:10.1096/fj.09-141275 · Cited by 157 · see citing works

Activation of Cannabinoid CB2 Receptor–Mediated AMPK/CREB Pathway Reduces Cerebral Ischemic Injury

Choi, I.-Y., Ju, C., Jalin, A. M. A. A., Lee, D. I., Prather, P. L., & Kim, W.-K. (2013) · American Journal Of Pathology · doi:10.1016/j.ajpath.2012.11.024 · Cited by 157 · see citing works

CB 1 cannabinoid receptors promote oxidative/nitrosative stress, inflammation and cell death in a murine nephropathy model

Mukhopadhyay, P., Pan, H., Rajesh, M., Bátkai, S., Patel, V., Harvey-White, J. D., Mukhopadhyay, B., Haskó, G., Gao, B., Mackie, K., et al. (2010) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2010.00769.x · Cited by 156 · see citing works

Cannabinoid‐1 receptor activation induces reactive oxygen species‐dependent and ‐independent mitogen‐activated protein kinase activation and cell death in human coronary artery endothelial cells

Rajesh, M., Mukhopadhyay, P., Haskó, G., Liaudet, L., Mackie, K., & Pacher, P. (2010) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2010.00712.x · Cited by 145 · see citing works

β-Caryophyllene ameliorates cisplatin-induced nephrotoxicity in a cannabinoid 2 receptor-dependent manner

Horváth, B., Mukhopadhyay, P., Kechrid, M., Patel, V., Tanchian, G., Wink, D. A., Gertsch, J., & Pacher, P. (2012) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2012.01.014 · Cited by 143 · see citing works

Monoacylglycerol Lipase Controls Endocannabinoid and Eicosanoid Signaling and Hepatic Injury in Mice

Cao, Z., Mulvihill, M. M., Mukhopadhyay, P., Xu, H., Erdélyi, K., Hao, E., Holovac, E., Haskó, G., Cravatt, B. F., Nomura, D. K., et al. (2013) · Gastroenterology · doi:10.1053/j.gastro.2012.12.028 · Cited by 142 · see citing works

The emerging role of the endocannabinoid system in cardiovascular disease

Pacher, P., & Steffens, S. (2009) · Seminars in Immunopathology · doi:10.1007/s00281-009-0145-8 · Cited by 139 · see citing works

Therapeutic Utility of Cannabinoid Receptor Type 2 (CB2) Selective Agonists

Han, S., Thatte, J., Buzard, D. J., & Jones, R. M. (2013) · Journal of Medicinal Chemistry · doi:10.1021/jm4005626 · Cited by 134 · see citing works

The cannabinoid receptor type 2 promotes cardiac myocyte and fibroblast survival and protects against ischemia/reperfusion‐induced cardiomyopathy

Defer, N., Wan, J., Souktani, R., Escoubet, B., Perier, M., Caramelle, P., Manin, S., Deveaux, V., Bourin, M., Zimmer, A., et al. (2009) · The FASEB Journal · doi:10.1096/fj.09-129478 · Cited by 133 · see citing works

Targeting cannabinoid receptor CB2in cardiovascular disorders: promises and controversies

Steffens, S., & Pacher, P. (2012) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2012.02042.x · Cited by 133 · see citing works

Neuroprotection in Oxidative Stress-Related Neurodegenerative Diseases: Role of Endocannabinoid System Modulation

Pálóczi, J., Varga, Z. V., Hasko, G., & Pacher, P. (2017) · Antioxidants and Redox Signaling · doi:10.1089/ars.2017.7144 · Cited by 121 · see citing works

Modulation of the Endocannabinoid System in Cardiovascular Disease

Pacher, P., Mukhopadhyay, P., Rajesh, M., Godlewski, G., Bátkai, S., & Kunos, G. (2008) · Hypertension · doi:10.1161/hypertensionaha.105.063651 · Cited by 121 · see citing works

Targeting the Cannabinoid Pathway Limits the Development of Fibrosis and Autoimmunity in a Mouse Model of Systemic Sclerosis

Servettaz, A., Kavian, N., Nicco, C., Deveaux, V., Chéreau, C., Wang, A., Zimmer, A., Lotersztajn, S., Weill, B. J., & Batteux, F. (2010) · American Journal Of Pathology · doi:10.2353/ajpath.2010.090763 · Cited by 119 · see citing works

A new cannabinoid CB2 receptor agonist HU‐910 attenuates oxidative stress, inflammation and cell death associated with hepatic ischaemia/reperfusion injury

Horváth, B., Magid, L., Mukhopadhyay, P., Bátkai, S., Rajesh, M., Park, O., Tanchian, G., Gao, R. Y., Goodfellow, C. E., Glass, M., et al. (2011) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2011.01381.x · Cited by 112 · see citing works

Medicinal Chemistry, Pharmacology, and Potential Therapeutic Benefits of Cannabinoid CB2Receptor Agonists

Tabrizi, M. A., Baraldi, P. G., Borea, P. A., & Varani, K. (2016) · Chemical Reviews · doi:10.1021/acs.chemrev.5b00411 · Cited by 110 · see citing works

Endocannabinoids and Traumatic Brain Injury

Mechoulam, R., & Shohami, E. (2007) · Molecular Neurobiology · doi:10.1007/s12035-007-8008-6 · Cited by 111 · see citing works

Ligand- and Heterodimer-Directed Signaling of the CB1 Cannabinoid Receptor

Hudson, B. D., Hébert, T. E., & Kelly, M. E. M. (2009) · Molecular Pharmacology · doi:10.1124/mol.109.060251 · Cited by 110 · see citing works

Perioperative care of cannabis users: A comprehensive review of pharmacological and anesthetic considerations

Echeverria-Villalobos, M., Todeschini, A. B., Stoicea, N., Fiorda‐Diaz, J., Weaver, T. E., & Bergese, S. D. (2019) · Journal of Clinical Anesthesia · doi:10.1016/j.jclinane.2019.03.011 · Cited by 109 · see citing works

Modulation of the Oxidative Stress and Lipid Peroxidation by Endocannabinoids and Their Lipid Analogues

Gallelli, C. A., Calcagnini, S., Romano, A., Koczwara, J. B., de Ceglia, M., Dante, D., Villani, R., Giudetti, A. M., Cassano, T., & Gaetani, S. (2018) · Antioxidants · doi:10.3390/antiox7070093 · Cited by 108 · see citing works

Anti-Obesity Effect of the CB2 Receptor Agonist JWH-015 in Diet-Induced Obese Mice

Verty, A. N. A., Stefanidis, A., McAinch, A. J., Hryciw, D. H., & Oldfield, B. J. (2015) · PLoS ONE · doi:10.1371/journal.pone.0140592 · Cited by 103 · see citing works

Modulation of Cannabinoid Receptor Activation as a Neuroprotective Strategy for EAE and Stroke

Zhang, M., Martin, B. R., Adler, M. W., Razdan, R. J., Kong, W., Ganea, D., & Tuma, R. F. (2009) · Journal of Neuroimmune Pharmacology · doi:10.1007/s11481-009-9148-4 · Cited by 101 · see citing works

Enhancement of endocannabinoid signaling by fatty acid amide hydrolase inhibition: A neuroprotective therapeutic modality

Hwang, J., Adamson, C. L., Butler, D., Janero, D. R., Makriyannis, A., & Bahr, B. A. (2009) · Life Sciences · doi:10.1016/j.lfs.2009.06.003 · Cited by 98 · see citing works

Endocannabinoid‐like N‐arachidonoyl serine is a novel pro‐angiogenic mediator

Zhang, X., Maor, Y., Jf, W., Kunos, G., & Groopman, J. (2010) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2010.00841.x · Cited by 94 · see citing works

A critical review of the cannabinoid receptor as a drug target for obesity management

Akbaş, F., Gasteyger, C., Sjödin, A. M., Astrup, A. V., & Larsen, T. M. (2008) · Obesity Reviews · doi:10.1111/j.1467-789x.2008.00520.x · Cited by 92 · see citing works

The endocannabinoid system as a target for the treatment of neuronal damage

Fernández‐Ruíz, J., García, C., Sagredo, O., Gómez‐Ruíz, M., & de Lago, E. (2010) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728221003709792 · Cited by 89 · see citing works

Endocannabinoids in cerebrovascular regulation

Benyó, Z., Ruisanchez, É., Leszl-Ishiguro, M., Sándor, P., & Pacher, P. (2016) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00571.2015 · Cited by 87 · see citing works

Functional Selectivity of CB2 Cannabinoid Receptor Ligands at a Canonical and Noncanonical Pathway

Dhopeshwarkar, A., & Mackie, K. (2016) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.116.232561 · Cited by 88 · see citing works

Interleukin-17 in post-stroke neurodegeneration

Swardfager, W., Winer, D. A., Herrmann, N., Winer, S., & Lanctôt, K. L. (2013) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2013.01.021 · Cited by 85 · see citing works

Mitochondrial CB1 receptor is involved in ACEA-induced protective effects on neurons and mitochondrial functions

Ma, L., Jia, J., Niu, W., Jiang, T., Zhai, Q., Yang, L., Bai, F., Wang, Q., & Xiong, L. (2015) · Scientific Reports · doi:10.1038/srep12440 · Cited by 86 · see citing works

Cannabinoid 1 receptor activation contributes to vascular inflammation and cell death in a mouse model of diabetic retinopathy and a human retinal cell line

El‐Remessy, A. B., Rajesh, M., Mukhopadhyay, P., Horváth, B., Patel, V., Al-Gayyar, M. M. H., Pillai, B. A., & Pacher, P. (2011) · Diabetologia · doi:10.1007/s00125-011-2061-4 · Cited by 83 · see citing works

Limb Remote Ischemic Conditioning: Mechanisms, Anesthetics, and the Potential for Expanding Therapeutic Options

Chen, G., Thakkar, M., Robinson, C. P., & Doré, S. (2018) · Frontiers in Neurology · doi:10.3389/fneur.2018.00040 · Cited by 83 · see citing works

Physical and functional interaction between CB1cannabinoid receptors and β2‐adrenoceptors

Hudson, B. D., Hébert, T. E., & Kelly, M. E. (2010) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2010.00681.x · Cited by 83 · see citing works

Endocannabinoids and the Heart

Hiley, C. R. (2009) · Journal of Cardiovascular Pharmacology · doi:10.1097/fjc.0b013e318192671d · Cited by 80 · see citing works

Modulation of cellular redox homeostasis by the endocannabinoid system

Lipina, C., & Hundal, H. S. (2016) · Open Biology · doi:10.1098/rsob.150276 · Cited by 80 · see citing works

Immune mechanisms in cerebral ischemic tolerance

García‐Bonilla, L., Benakis, C., Moore, J. M. R., Iadecola, C., & Anrather, J. (2014) · Frontiers in Neuroscience · doi:10.3389/fnins.2014.00044 · Cited by 79 · see citing works

Fatty acid amide hydrolase is a key regulator of endocannabinoid-induced myocardial tissue injury

Mukhopadhyay, P., Horváth, B., Rajesh, M., Matsumoto, S., Saito, K., Bátkai, S., Patel, V., Tanchian, G., Gao, R. Y., Cravatt, B. F., et al. (2010) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2010.11.002 · Cited by 79 · see citing works

Activation of Cannabinoid CB2 Receptor Ameliorates Atherosclerosis Associated With Suppression of Adhesion Molecules

Zhao, Y., Yuan, Z., Liu, Y., Xue, J., Tian, Y., Liu, W., Zhang, W., Shen, Y., Xu, W., Liang, X., et al. (2010) · Journal of Cardiovascular Pharmacology · doi:10.1097/fjc.0b013e3181d2644d · Cited by 80 · see citing works

Pepcan-12 (RVD-hemopressin) is a CB2 receptor positive allosteric modulator constitutively secreted by adrenals and in liver upon tissue damage

Petrucci, V., Chicca, A., Glasmacher, S., Pálóczi, J., Cao, Z., Pacher, P., & Gertsch, J. (2017) · Scientific Reports · doi:10.1038/s41598-017-09808-8 · Cited by 75 · see citing works

Activation of Cannabinoid Type 2 Receptor by JWH133 Protects Heart Against Ischemia/Reperfusion-Induced Apoptosis

Li, Q., Wang, F., Zhang, Y.-M., Zhou, J., & Zhang, Y. (2013) · Cellular Physiology and Biochemistry · doi:10.1159/000350088 · Cited by 71 · see citing works

Cannabinoid receptor-specific mechanisms to alleviate pain in sickle cell anemia via inhibition of mast cell activation and neurogenic inflammation

Vincent, L., Vang, D., Nguyen, J., Benson, B. A., Lei, J.-X., & Gupta, K. (2015) · Haematologica · doi:10.3324/haematol.2015.136523 · Cited by 68 · see citing works

CB2 Cannabinoid Receptors Contribute to Bacterial Invasion and Mortality in Polymicrobial Sepsis

Csóka, B., Németh, Z. H., Mukhopadhyay, P., Spolarics, Z., Rajesh, M., Federici, S., Deitch, E. A., Bátkai, S., Pacher, P., & Haskó, G. (2009) · PLoS ONE · doi:10.1371/journal.pone.0006409 · Cited by 67 · see citing works

Cannabinoid-2 Receptor Activation Protects Against Infarct and Ischemia–Reperfusion Heart Injury

Wang, P., Jiang, L.-S., Bu, J., Huang, X.-J., Song, W., Du, Y.-P., & He, B. (2011) · Journal of Cardiovascular Pharmacology · doi:10.1097/fjc.0b013e3182418997 · Cited by 67 · see citing works

Endocannabinoid involvement in endometriosis.

Dmitrieva, N., Nagabukuro, H., Resuehr, D., Zhang, G., McAllister, S. L., McGinty, K. A., Mackie, K., & Berkley, K. J. (2010) · Pain · doi:10.1016/j.pain.2010.08.037 · Cited by 64 · see citing works

Equipotent Inhibition of Fatty Acid Amide Hydrolase and Monoacylglycerol Lipase – Dual Targets of the Endocannabinoid System to Protect against Seizure Pathology

Naidoo, V., Karanian, D. A., Vadivel, S. K., Locklear, J. R., Wood, J. T., Nasr, M. L., Quizon, P. M., Graves, E. E., Shukla, V. G., Makriyannis, A., et al. (2012) · Neurotherapeutics · doi:10.1007/s13311-011-0100-y · Cited by 60 · see citing works

Cannabinoid CB1 receptor inhibition decreases vascular smooth muscle migration and proliferation

Rajesh, M., Mukhopadhyay, P., Haskó, G., & Pacher, P. (2008) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2008.10.159 · Cited by 60 · see citing works

Endocannabinoids and cardiac contractile function: Pathophysiological implications

Bátkai, S., & Pacher, P. (2009) · Pharmacological Research · doi:10.1016/j.phrs.2009.04.003 · Cited by 57 · see citing works

Phytocannabinoids and Endocannabinoids

Fišar, Z. (2009) · Current Drug Abuse Reviews · doi:10.2174/1874473710902010051 · Cited by 56 · see citing works

Effect and mechanism of salvianolic acid B on the myocardial ischemia-reperfusion injury in rats

Xue, L., Wu, Z. F., Ji, X., Gao, X.-Q., & Guo, Y.-H. (2014) · Asian Pacific Journal of Tropical Medicine · doi:10.1016/s1995-7645(14)60038-9 · Cited by 55 · see citing works

Bioactive Lipid Signaling in Cardiovascular Disease, Development, and Regeneration

Wasserman, A. H., Venkatesan, M., & Aguirre, A. (2020) · Cells · doi:10.3390/cells9061391 · Cited by 50 · see citing works

Cannabinoid/agonist WIN 55,212‐2 reduces cardiac ischaemia–reperfusion injury in Zucker diabetic fatty rats: role of CB2 receptors and iNOS/eNOS

González, C., Herradón, E., Abalo, R., Vera, G., Perez‐Nievas, B. G., Leza, J. C., Martin, M., & López‐Miranda, V. (2011) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.1176 · Cited by 53 · see citing works

Acute upregulation of neuronal mitochondrial type-1 cannabinoid receptor and it’s role in metabolic defects and neuronal apoptosis after TBI

Xu, Z., Lv, X., Dai, Q., Ge, Y., & Xu, J. (2016) · Molecular Brain · doi:10.1186/s13041-016-0257-8 · Cited by 53 · see citing works

Predictors of malignant cerebral edema in cerebral artery infarction: A meta-analysis

Miao, J., Song, X., Sun, W., Qiu, X., Lan, Y., & Zhou, Z. (2019) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2019.116607 · Cited by 52 · see citing works

Neuroprotective effects of N-stearoyltyrosine on transient global cerebral ischemia in gerbils.

Zhang, Y.-B., Kan, M., Yang, Z.-H., Ding, W.-L., Yi, J., Chen, H.-Z., & Lu, Y. (2009) · Brain Research · doi:10.1016/j.brainres.2009.06.070 · Cited by 47 · see citing works

Post‐ischemic brain damage: the endocannabinoid system in the mechanisms of neuronal death

Pellegrini-Giampietro, D. E., Mannaioni, G., & Bagetta, G. (2008) · FEBS Journal · doi:10.1111/j.1742-4658.2008.06765.x · Cited by 50 · see citing works

Endocannabinoids and Liver Disease. III. Endocannabinoid effects on immune cells: implications for inflammatory liver diseases

Pacher, P., & Gao, B. (2008) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00523.2007 · Cited by 51 · see citing works

Pharmacological Properties, Therapeutic Potential and Molecular Mechanisms of JWH133, a CB2 Receptor-Selective Agonist

Hashiesh, H. M., Sharma, C., Goyal, S. N., Jha, N. K., & Ojha, S. K. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.702675 · Cited by 49 · see citing works

Time‐Dependent Vascular Effects of Endocannabinoids Mediated by Peroxisome Proliferator‐Activated Receptor Gamma (PPARγ)

O’Sullivan, S. E., Kendall, D. A., & Randall, M. D. (2009) · PPAR Research · doi:10.1155/2009/425289 · Cited by 49 · see citing works

The cannabinoid CB1 receptor antagonist, rimonabant, protects against acute myocardial infarction

Lim, S. Y., Davidson, S. M., Yellon, D. M., & Smith, C. (2009) · Basic Research in Cardiology · doi:10.1007/s00395-009-0034-2 · Cited by 49 · see citing works

An ultra-low dose of tetrahydrocannabinol provides cardioprotection

Waldman, M., Hochhauser, E., Fishbein, M., Aravot, D. J., Shainberg, A., & Sarne, Y. (2013) · Biochemical Pharmacology · doi:10.1016/j.bcp.2013.03.014 · Cited by 48 · see citing works

Ischemia/reperfusion injury in liver resection: A review of preconditioning methods

Theodoraki, K. A., Tympa, A., Karmaniolou, I. I., Τsaroucha, A., Arkadopoulos, N. F., & Smyrniotis, V. E. (2011) · Surgery Today · doi:10.1007/s00595-010-4444-4 · Cited by 48 · see citing works

Rational design, synthesis and anti-proliferative properties of new CB2 selective cannabinoid receptor ligands: An investigation of the 1,8-naphthyridin-2(1H)-one scaffold

Manera, C., Saccomanni, G., Malfitano, A. M., Bertini, S., Castelli, F., Laezza, C., Ligresti, A., Lucchesi, V., Tuccinardi, T., Rizzolio, F., et al. (2012) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2012.03.031 · Cited by 48 · see citing works

Anandamide enhances expression of heat shock protein 72 to protect against ischemia–reperfusion injury in rat heart

Li, Q., Shi, M., & Li, B. (2012) · The Journal of Physiological Sciences · doi:10.1007/s12576-012-0228-5 · Cited by 47 · see citing works

Normal aging in rats and pathological aging in human Alzheimer’s disease decrease FAAH activity: Modulation by cannabinoid agonists

Pascual, A. C., Martín-Moreno, A. M., Giusto, N. M., CEBALLOS, M. L. D., & Pasquaré, S. J. (2014) · Experimental Gerontology · doi:10.1016/j.exger.2014.10.011 · Cited by 46 · see citing works

Effects of melatonin in experimental stroke models in acute, sub-acute, and chronic stages

Lin, H., & Lee (2009) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s4815 · Cited by 46 · see citing works

Δ8‐Tetrahydrocannabivarin prevents hepatic ischaemia/reperfusion injury by decreasing oxidative stress and inflammatory responses through cannabinoid CB2 receptors

Bátkai, S., Mukhopadhyay, P., Horváth, B., Rajesh, M., Gao, R. Y., Mahadevan, A., Mukkanti, A., Battista, N., Lichtman, A. H., Gauson, L. A., et al. (2011) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2011.01410.x · Cited by 45 · see citing works

The cannabinoid WIN55,212-2 protects against oxidized LDL-induced inflammatory response in murine macrophages

Hao, M., Jiang, L.-S., Fang, N., Pu, J., Hu, L., Shen, L., Song, W., & He, B. (2010) · Journal of Lipid Research · doi:10.1194/jlr.m001511 · Cited by 45 · see citing works

The endocannabinoidome in neuropsychiatry: Opportunities and potential risks

Morris, G., Walder, K. R., Kloiber, S. M., Amminger, G. P., Berk, M., Bortolasci, C. C., Maes, M. H. J., Puri, B. K., & Carvalho, A. F. (2021) · Pharmacological Research · doi:10.1016/j.phrs.2021.105729 · Cited by 47 · see citing works

Cannabinoid receptor CB2 is expressed on vascular cells, but not astroglial cells in the post-mortem human Huntington's disease brain

Dowie, M. J., Grimsey, N. L., Hoffman, T., Faull, R. L. M., & Glass, M. (2014) · Journal of Chemical Neuroanatomy · doi:10.1016/j.jchemneu.2014.06.004 · Cited by 44 · see citing works

CB2 Receptor Activation Ameliorates the Proinflammatory Activity in Acute Lung Injury Induced by Paraquat

Liu, Z., Wang, Y., Zhao, H., Zheng, Q., Xiao, L., & Zhao, M. (2014) · BioMed Research International · doi:10.1155/2014/971750 · Cited by 42 · see citing works

Synthetic Cannabinoids and Cathinones Cardiotoxicity: Facts and Perspectives

Radaelli, D., Manfredi, A., Zanon, M., Fattorini, P., Scopetti, M., Neri, M., Frisoni, P., & D’Errico, S. (2021) · Current Neuropharmacology · doi:10.2174/1570159x19666210412101929 · Cited by 42 · see citing works

Update on the Role of Cannabinoid Receptors after Ischemic Stroke

Capettini, L. D. S. A., Savergnini, S. Q., da Silva, R., Stergiopulos, N., Santos, R. A. S., Mach, F., & Montecucco, F. (2012) · Mediators of Inflammation · doi:10.1155/2012/824093 · Cited by 41 · see citing works

Targeting pain at its source in sickle cell disease

Gupta, K., Jahagirdar, O. B., & Gupta, K. (2018) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00021.2018 · Cited by 43 · see citing works

Prussian Blue Scavenger Ameliorates Hepatic Ischemia-Reperfusion Injury by Inhibiting Inflammation and Reducing Oxidative Stress

Huang, Y., Xu, Q., Zhang, J., Yin, Y., Pan, Y., Zheng, Y., Cai, X., Xia, Q., & He, K. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.891351 · Cited by 41 · see citing works

The role of the endocannabinoid system in liver diseases

Caraceni, P., Domenicali, M., Giannone, F. A., & Bernardi, M. (2009) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2008.10.009 · Cited by 41 · see citing works

Cannabinoids in the Cardiovascular System

Ho, W. ‐. V., & Kelly, M. E. M. (2017) · Advances in pharmacology · doi:10.1016/bs.apha.2017.05.002 · Cited by 40 · see citing works

Activation of cannabinoid type 2 receptor protects skeletal muscle from ischemia-reperfusion injury partly via Nrf2 signaling

Zhang, M., Zhang, M., Wang, L., Yu, T.-S., Jiang, S., Jiang, P., Sun, Y., Pi, J., Zhao, R., & Guan, D.-W. (2019) · Life Sciences · doi:10.1016/j.lfs.2019.05.056 · Cited by 39 · see citing works

Pre- and post-conditioning treatment with an ultra-low dose of Δ9-tetrahydrocannabinol (THC) protects against pentylenetetrazole (PTZ)-induced cognitive damage

Assaf, F., Fishbein, M., Gafni, M., Keren, O., & Sarne, Y. (2011) · Behavioural Brain Research · doi:10.1016/j.bbr.2011.02.005 · Cited by 40 · see citing works

Increased Renal 2-Arachidonoylglycerol Level Is Associated with Improved Renal Function in a Mouse Model of Acute Kidney Injury

Moradi, H., Oveisi, F., Khanifar, E., Moreno‐Sanz, G., Vaziri, N. D., & Piomelli, D. (2016) · Cannabis and Cannabinoid Research · doi:10.1089/can.2016.0013 · Cited by 37 · see citing works

Therapeutical Potential of CB2 Receptors in Immune-Related Diseases

Leleu‐Chavain, N., Desreumaux, P., Chavatte, P., & Millet, R. (2014) · Current Molecular Pharmacology · doi:10.2174/1874467207666140219122337 · Cited by 35 · see citing works

Predicting futile recanalization, malignant cerebral edema, and cerebral herniation using intelligible ensemble machine learning following mechanical thrombectomy for acute ischemic stroke

Zeng, W., Li, W., Huang, K., Lin, Z., Dai, H., He, Z., Liu, R., Zeng, Z., Qin, G., Chen, W., et al. (2022) · Frontiers in Neurology · doi:10.3389/fneur.2022.982783 · Cited by 34 · see citing works

Role of CB 2 Receptor in the Recovery of Mice after Traumatic Brain Injury

Magid, L., Heymann, S., Elgali, M., Avram, L., Cohen, Y., Zaltsman, S. L., Mechoulam, R., & Shohami, E. (2018) · Journal of Neurotrauma · doi:10.1089/neu.2018.6063 · Cited by 34 · see citing works

CB1 receptors and post-ischemic brain damage: Studies on the toxic and neuroprotective effects of cannabinoids in rat organotypic hippocampal slices

Landucci, E., Scartabelli, T., Gerace, E., Moroni, F., & Pellegrini-Giampietro, D. E. (2010) · Neuropharmacology · doi:10.1016/j.neuropharm.2010.11.021 · Cited by 33 · see citing works

The Role of CB1 and CB2 Cannabinoid Receptors in Myocardial Ischemia-Reperfusion Injury: Cardioprotective and Vasculoprotective Effects (a literature review)

Stepanov, I. V., Gorbunov, A. S., & Маслов, Л. Н. (2026) · Сибирский журнал клинической и экспериментальной медицины · doi:10.29001/2073-8552-2026-3133

Cannabinoid‐2 receptor mediates protection against hepatic ischemia/reperfusion injury

Bátkai, S., Osei‐Hyiaman, D., Pan, H., El-Assal, O. N., Rajesh, M., Mukhopadhyay, P., Hong, F., Harvey-White, J. D., Jafri, A., Haskó, G., et al. (2007) · The FASEB Journal · doi:10.1096/fj.06-7451com · Cited by 246 · see citing works

Cannabinoid-2 Receptor Activation Protects Against Infarct and Ischemia–Reperfusion Heart Injury

Wang, P., Jiang, L.-S., Bu, J., Huang, X.-J., Song, W., Du, Y.-P., & He, B. (2011) · Journal of Cardiovascular Pharmacology · doi:10.1097/fjc.0b013e3182418997 · Cited by 67 · see citing works

Endogenous cannabinoids contribute to remote ischemic preconditioning via cannabinoid CB2 receptors in the rat heart

Hajrasouliha, A. R., Tavakoli, S., Ghasemi, M., Maralani, P. J., Sadeghipour, H., Ebrahimi, F., & Dehpour, A. R. (2007) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2007.09.034 · Cited by 105 · see citing works

Cannabinoid CB1/CB2 Receptors in the Heart: Expression, Regulation, and Function

Kaschina, E. (2016) · InTech eBooks · doi:10.5772/62822 · Cited by 23 · see citing works